Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Generation Bio Co. (NASDAQ:GBIO – Get Rating) have been given an average rating of “Moderate Buy” by the six research firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average […]
Generation Bio Co. (NASDAQ:GBIO – Get Rating) COO Antoinette Paone sold 2,914 shares of the business’s stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $4.61, for a total value of $13,433.54. The sale was disclosed in a filing with the SEC, which is accessible through the […]
The growing demand for novel drugs, which hold potential for the treatment of previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery
CAMBRIDGE, Mass., April 11, 2023 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough,... | April 11, 2023
CAMBRIDGE, Mass., April 05, 2023 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Yalonda Howze, J.D.... | April 5, 2023